Variability in Vedolizumab Exposure Between Patients With Inflammatory Bowel Disease

被引：0
|
作者：
Gils, Ann
Dreesen, Erwin
Peeters, Miet
Brouwers, Els
Ferrante, Marc
Van Assche, Gert
Vermeire, Severine
机构：
来源：
GASTROENTEROLOGY | 2016年 / 150卷 / 04期
关键词：
D O I：
10.1016/S0016-5085(16)31431-7
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Sa1943
引用
收藏
页码：S411 / S412
页数：2
相关论文
共 50 条
  • [21] Predictors of Vedolizumab Dose Escalation or Cessation in Inflammatory Bowel Disease Patients
    Razvi, Mohammed A.
    Chowdhury, Reezwana
    Parian, Alyssa
    Melia, Joanna
    Truta, Brindusa
    Brant, Steve
    Dudley-Brown, Sharon
    Lazarev, Mark
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 : S417 - S418
  • [22] Effectiveness and Safety of Vedolizumab Induction Therapy for Patients With Inflammatory Bowel Disease
    Amiot, Aurelien
    Grimaud, Jean-Charles
    Peyrin-Biroulet, Laurent
    Filippi, Jerome
    Pariente, Benjamin
    Roblin, Xavier
    Buisson, Anthony
    Stefanescu, Carmen
    Trang-Poisson, Caroline
    Altwegg, Romain
    Marteau, Philippe
    Vaysse, Thibaud
    Bourrier, Anne
    Nancey, Stephane
    Laharie, David
    Allez, Matthieu
    Savoye, Guillaume
    Moreau, Jacques
    Gagniere, Charlotte
    Vuitton, Lucine
    Viennot, Stephanie
    Aubourg, Alexandre
    Pelletier, Anne-Laure
    Bouguen, Guillaume
    Abitbol, Vered
    Bouhnik, Yoram
    [J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2016, 14 (11) : 1593 - +
  • [23] Efficacy of Vedolizumab in a Nationwide Cohort of Elderly Inflammatory Bowel Disease Patients
    Khan, Nabeel
    Pernes, Tyler
    Weiss, Alexandra
    Trivedi, Chinmay
    Patel, Manthankumar
    Medvedeva, Elina
    Xie, Dawei
    Yang, Yu-Xiao
    [J]. INFLAMMATORY BOWEL DISEASES, 2022, 28 (05) : 734 - 744
  • [24] Predicting Response to Vedolizumab in Inflammatory Bowel Disease
    Meserve, Joseph
    Dulai, Parambir
    [J]. FRONTIERS IN MEDICINE, 2020, 7
  • [25] A product review of vedolizumab in inflammatory bowel disease
    Battat, Robert
    Dulai, Parambir S.
    Jairath, Vipul
    Vande Casteele, Niels
    [J]. HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2019, 15 (10) : 2482 - 2490
  • [26] Vedolizumab in the Perioperative Management of Inflammatory Bowel Disease
    Lightner, Amy L.
    Loftus, Edward V., Jr.
    McKenna, Nicholas P.
    Raffals, Laura E.
    [J]. CURRENT DRUG TARGETS, 2019, 20 (13) : 1317 - 1322
  • [27] Incidence of joint symptoms in patients with inflammatory bowel disease on treatment with vedolizumab
    Ruiz-Ramirez, M. A.
    Rodriguez-Merlos, P.
    Suarez, C.
    Plasencia-Rodriguez, C.
    Navarro-Compan, V.
    Poza, J.
    Martin-Arranz, E.
    Sanchez-Azofra, M.
    Rueda-Garcia, J. L.
    Garcia-Ramirez, L.
    Franco, K.
    Bonilla, G.
    Peiteado, D.
    Balsa, A.
    Martin-Arranz, M. D.
    [J]. JOURNAL OF CROHNS & COLITIS, 2020, 14 : S473 - S473
  • [28] Effect of Vedolizumab on Anemia of Chronic Disease in Patients with Inflammatory Bowel Diseases
    Scarozza, Patrizio
    De Cristofaro, Elena
    Scucchi, Ludovica
    Rocchetti, Irene
    Marafini, Irene
    Neri, Benedetto
    Salvatori, Silvia
    Biancone, Livia
    Calabrese, Emma
    Monteleone, Giovanni
    [J]. JOURNAL OF CLINICAL MEDICINE, 2020, 9 (07) : 1 - 10
  • [29] Safety and Efficacy of Vedolizumab Use in Older Patients With Inflammatory Bowel Disease
    Shivashankar, Raina
    Aberra, Faten
    Ladd, Antonio Mendoza
    Lichtenstein, Gary R.
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 : S404 - S405
  • [30] The Effect of Vedolizumab on Spondyloarthritis Symptoms in a Cohort of Inflammatory Bowel Disease Patients
    Huseynzada, Sinakhanim
    Inel, Tuba Yuce
    Hajiyev, Farid
    Avsar, Aydan Koken
    Balci, Ali
    Akpinar, Hale
    Onen, Fatos
    Sari, Ismail
    [J]. EUROPEAN JOURNAL OF RHEUMATOLOGY, 2023, 10 (02) : 50 - +
12345